Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides | Zendy

L Wondrack | Zendy; Mark A. Massa | Zendy; Bingwei Yang | Zendy; Joyce A. Sutcliffe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides

Author(s) -

L Wondrack,

Mark A. Massa,

Bingwei Yang,

Joyce A. Sutcliffe

Publication year - 1996

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.40.4.992

Subject(s) - efflux , staphylococcus aureus , microbiology and biotechnology , erythromycin , strain (injury) , escherichia coli , esterase , biology , staphylococcus , bacteria , chemistry , enzyme , antibiotics , biochemistry , gene , genetics , anatomy

Searching through a collection of 124 Staphylococcus aureus clinical strains, we found one isolate, strain 01A1032, that inactivates 14- and 16-membered macrolides. The products of inactivation were purified from supernatant fluids of cultures exposed to erythromycin for 3 h and were found to be identical to products of inactivation from Escherichia coli strains that encode either an EreA or EreB esterase. Further, strain 01A1032 was shown to be resistant to azithromycin, a 15-membered macrolide, by an alternate mechanism, efflux. Thus, strain 01A1032 harbors determinants encoding an esterase activity that hydrolyzes 14- and 16-membered macrolides and a macrolide efflux system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research